Top

BY Clayton R. Boldt, Ph.D.

MD Anderson Cancer Center researchers, together with collaborators from Mozambique, Brazil and the U.S., have been awarded a $5.1 million grant to evaluate innovative approaches to increase screening and prevention of cervical cancers in Mozambique, which has some of the highest rates of cervical cancer in the world.

The grant was awarded by the Partnerships for Enhanced Engagement in Research (PEER) program, sponsored by the U.S...

A collaborative project involving researchers from MD Anderson has been awarded a $5.1 million grant to evaluate innovative approaches to increase screening and prevention of cervical cancers in Mozambique.

BY Kellie Bramlet Blackburn

In recent years, the surgical technique sentinel lymph node biopsy has allowed surgeons to more accurately determine how far cancer has spread...

BY Clayton R. Boldt, Ph.D.

Despite the availability of vaccines that could prevent the majority of cancers caused by the human papillomavirus (HPV), the incidence of...

BY Kathryn Boom

In Texas, the number is even lower. Only 33% of Texas teens were up to date. That’s a lot of room for improvement.

Having spent the past two summers with Kathleen Schmeler, M.D., a gynecologic oncologist at MD Anderson Cancer Center and Lyndon B. Johnson (LBJ) Hospital, I’ve seen firsthand the devastation cervical cancer can cause. I’ve seen wives, mothers and daughters suffering and dying from an avoidable disease.

I’ve...

HPV vaccine

BY MD Anderson staff

World Cancer Day is Saturday, Feb. 4. It’s the one singular initiative under which the entire world unites to fight cancer through prevention...

BY Clayton Boldt, Ph.D.

Cervical cancer is the fourth most common cancer among women worldwide and was responsible for approximately 266,000 deaths in 2012, according...

BY Ronda Wendler

A program designed to reduce cervical- and breast-cancer deaths among women in developing countries is celebrating its fifth anniversary this...

BY MD Anderson staff

The Food and Drug Administration’s (FDA) approval of a new vaccine that targets five additional strains of human papillomavirus (HPV) fortifies...